IQVIA Holdings (STU:QTS) Total Receivables: €2,919 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:QTS IQVIA Holdings Inc STU:QTS
89 GF Score
Price €182.05
GF Value €219.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Total Receivables?

IQVIA Holdings STU:QTS -0.05% 89 Total Receivables is €2,919 Mil as of Mar. 2026. GuruFocus rates STU:QTS with a GF Score™ of 89/100 and a GF Value™ of €219.16 (Modestly Undervalued). The stock has 3 warning signs investors should review.

IQVIA Holdings's Total Receivables for the quarter that ended in Mar. 2026 was €2,919 Mil.

IQVIA Holdings Total Receivables Related Terms

IQVIA Holdings Total Receivables Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Total Receivables Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,308.97 2,794.24 3,129.72 3,094.20 2,926.66

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,062.68 2,953.00 2,823.53 2,926.66 2,919.38
STU:QTS
89GF Score
IQVIA Holdings Inc STU:QTS
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €2,919 Mil mean?
IQVIA Holdings (STU:QTS) has a Total Receivables of €2,919 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Total Receivables too high?
IQVIA Holdings' current Total Receivables is €2,919 Mil. Overall, IQVIA Holdings has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Total Receivables compare to WAT and ILMN?
IQVIA Holdings' Total Receivables of €2,919 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Diagnostics & Research company?
A good Total Receivables depends on the Medical Diagnostics & Research industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Total Receivables is €2,919 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (STU:QTS) is currently considered Modestly Undervalued. The stock's GF Value™ is €219.16, compared to a current price of €182.05 — trading 16.9% below its estimated fair value. The current Total Receivables is €2,919 Mil. IQVIA Holdings' overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For IQVIA Holdings (STU:QTS), the current Total Receivables is €2,919 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (STU:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €182.05 is trading 16.9% below its estimated GF Value™ of €219.16. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for STU:QTS:

  • Total Receivables: €2,919 Mil
  • GF Value™: €219.16 vs. price of €182.05 (16.9% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the STU:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
89GF Score

Get the complete analysis for STU:QTS

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€182.05
Price
€219.16
GF Value